Skip to main navigation Skip to search Skip to main content

Costimulation via CD55 on human CD4+ T cells mediated by CD97

  • Melania Capasso
  • , Lindy G. Durrant
  • , Martin Stacey
  • , Siamon Gordon
  • , Judith Ramage
  • , Ian Spendlove*
  • *Corresponding author for this work
  • University of Nottingham
  • University of Oxford

Research output: Contribution to journalJournal Article peer-review

99 Scopus citations

Abstract

Decay-accelerating factor (CD55) is a complement regulatory protein, which is expressed by most cells to protect them from complement-mediated attack. CD55 also binds CD97, an EGF-TM7 receptor constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells upon activation. Early results suggested that CD55 could further enhance T cell proliferation induced by phorbol ester treatment. The present study demonstrates that coengagement of CD55, using either cross-linking mAbs or its natural ligand CB97, and CD3 results in enhanced proliferation of human peripheral blood CD4+ T cells, expression of the activation markers CD69 and CD25, and secretion of IL-10 and GM-CSF. Recently, an increase in T cell respoesiveness in CD55 -/- mice was shown to be mediated by a lack of complement regulation. To this study, we show that direct stimulation of CD55 on CD4+ T cells with CD97 can modulate T cell activation but does not interfere with CD55-mediated complement regulation. Our results support a multifaceted role for CD55 in human T cell activation, constituting a further link between innate and adaptive immunity.

Original languageEnglish
Pages (from-to)1070-1077
Number of pages8
JournalJournal of Immunology
Volume177
Issue number2
DOIs
StatePublished - 15 07 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Costimulation via CD55 on human CD4+ T cells mediated by CD97'. Together they form a unique fingerprint.

Cite this